C07D 211/50
Aroyl radical
C07D211/50 (Aroyl radical) appears on 13 US grants and 10 published applications in this corpus.
Search patents in C07D- Granted patents
- 13
- Published applications
- 10
- Assignees
- 9
- Inventors
- 24
- Latest grant
- 5 Feb 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 2 | 2 |
| 2015 | 2 | 3 |
| 2016 | 0 | 0 |
| 2017 | 3 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Hepatitis B antiviral agents5 Feb 2019US 10,196,376 B2Novira Therapeutics, Inc.
- Hepatitis B antiviral agents5 Sep 2017US 9,751,857 B2Novira Therapeutics, Inc.
- Hepatitis B antiviral agents13 Jun 2017US 9,676,747 B2Novira Therapeutics, Inc.
- Prophylactic agent and/or therapeutic agent for stress urinary incontinence28 Mar 2017US 9,603,845 B2Taiho Pharmaceutical Co., Ltd.
- Hepatitis B antiviral agents30 Jun 2015US 9,066,932 B2Novira Therapeutics, Inc.
- Compositions and methods for treating neurodegenerative diseases and disorders14 Mar 2024US 2024/0083839 A1The Regents of the University of California
- Hepatitis b antiviral agents23 Nov 2017US 2017/0334882 A1Novira Therapeutics, Inc.
- Hepatitis b antiviral agents17 Sep 2015US 2015/0259324 A1Novira Therapeutics, Inc.
- Hepatitis B Antiviral Agents4 Jun 2015US 2015/0152073 A1Novira Therapeutics, Inc.
- Prophylactic agent and/or therapeutic agent for stress urinary incontinence19 Feb 2015US 2015/0051250 A1Taiho Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Hepatitis B antiviral agents47US 8,629,274 B2Novira Therapeutics, Inc. · 2014
- Hepatitis B antiviral agents37US 9,061,008 B2Novira Therapeutics, Inc. · 2015
- Hepatitis B antiviral agents37US 9,066,932 B2Novira Therapeutics, Inc. · 2015
- Hepatitis B antiviral agents20US 9,676,747 B2Novira Therapeutics, Inc. · 2017
- Liquid crystalline piperidine derivatives12US 4,537,698 AMerck Patent GmbH · 1985